Clinical and Molecular Investigations Into Ciliopathies
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00068224|
Recruitment Status : Recruiting
First Posted : September 10, 2003
Last Update Posted : October 7, 2019
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Clinical and Molecular Investigations Into Ciliopathies|
|Study Start Date :||September 8, 2003|
Children and adults who carry a clinical diagnosis of a known ciliopathy and those patients who have typical features suggestive of a cliopathy but not fulfilling the diagnostic criteria.
- Ciliopathy [ Time Frame: ongoing ]The general objective of this study is to assess the clinical characteristics of ciliopathies.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00068224
|Contact: Meral Gunay-Aygun, M.D.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Meral Gunay-Aygun, M.D.||National Human Genome Research Institute (NHGRI)|